Aurora Cannabis Inc (NASDAQ: ACB) is in focus today after buying the remaining 90% stake in MedReleaf Australia for about AU$50 million ($32.45 million). Details of Aurora-MedReleaf transaction The...

Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-rel...

The last decade saw a trend for destigmatization of the use of psychoactive substances accompanied by a wave of legislation either legalizing or decriminalizing mostly marijuana-based products – bo...

Cannabis stocks are notching their second day of gains after the Drug Enforcement Administration confirmed it's reviewing an August recommendation from the U.S. Department of Health and Human Servi...

Aurora Cannabis's financials have been improving and the company posted record adjusted EBITDA last quarter. The company's focus on the medical marijuana market has allowed it to generate better ma...

There is much anticipation about how marijuana stocks will trade during 2024. There is a lot in the works that stands a good chance to help the sector trade up. In 2024 we will see a continued effo...

The cannabis sector and top marijuana stocks in 2023 stand at a pivotal point, marked by significant growth and evolving regulatory landscapes. This article explores the sector's current state, fut...

Left for dead by the stock market, Aurora Cannabis is starting to show signs of life in 2023. By 2024, the company may be generating positive free cash flow, and could even earn a profit.

In the rapidly evolving world of cannabis investments, ancillary marijuana stocks present a unique opportunity for investors looking beyond the conventional market. These stocks, which represent co...

Aurora Cannabis delivered powerful revenue growth in its last earnings report. Its losses are slimming -- and the potential for profits is growing.

Aurora Cannabis' latest financial results were decent, but that doesn't make up for years of poor performance. Biogen has proven it can be a highly innovative biotech, but it will take more than th...

Things are looking up for Aurora Cannabis in several ways. However, the Canadian cannabis producer still faces several challenges.

As December 2023 arrives, Canadian cannabis stocks are increasingly capturing the attention of investors worldwide. The global cannabis industry has been on a steady rise, with projections indicati...

Cannabis has undoubtedly taken ground within the medical and recreational world. A review of several analyst opinions in different financial sources shows these three companies with good opinions a...

An end to federal prohibition may be in reach, according to Senate Majority Leader Chuck Schumer. All thanks to bipartisan legislation that could give the industry access to banking services.